Lukas M Carter

Nov 10, 2023 | jnm.snmjournals.org | David Bauer |Lukas M Carter |Mohamed I. Atmane |Roberto De Gregorio

A therapy study was conducted with [212Pb]Pb-DO3A-PEG7-Tz (single administration) comprising 5 arms (n = 8 per cohort) with 2 control and 3 therapeutic groups. The 2 control arms consisted of one group that received only 5B1-TCO and one that received an unspecific IgG-TCO mAb followed by administration of 1.1 MBq of [212Pb]Pb-DO3A-PEG7-Tz 3 d later.